The industry of stem cell therapy is experiencing rapid growth, attracting both considerable investment and intense public attention. This multifaceted financial landscape is defined by a range of variables, including governmental frameworks, clinical trial costs, and the shifting demands of the patient population. Understanding this landscape is c

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These methods involve small incisions and minimal tissue manipulation, resulting in quicker recovery times, redu